What are the side effects of Apelix?

Alpelisib(Alpelisib) is a kinase inhibitor used in combination with fulvestrant to treat hormone receptor (HR)-positive, human epidermal growth factor receptor2(her Adult patients with 2)-negative, PIK3CA mutated advanced or metastatic breast cancer detected by an FDA-approved test after progression on an endocrine-based regimen.

Alpelisib(Alpelisib)Common side effects includeincreased blood sugar (79%)< /span>, Elevated creatinine (67%), Diarrhea (58%), Skin rash (52%), Lymphocyte count decreased (52%), GGTincreased52%, nausea (45%), alanine aminotransferase increased ( 44% 2%), Elevated blood sugar, 3-4 grade (39%), Decreased appetite (36%). (27%), Glucose drop (26%), aPTTprolongation21%, hair loss (20 %), Skin rash, 3-4 grade (20%), Mucosal inflammation (19%),Pruritus (18%), Dry skin (18%), Dysgeusia (18%), Headache (18%), Abdominal pain (17%), Peripheral edema (15%), Fever ( >14%), Platelet count decreased (14%), Potassium decreased (14%), Albumin decreased ( 14%), dry mucous membranes (12%), indigestion (11%), decreased magnesium content11%, etc. If you want to get more high-quality information, you can contact YaoDe. YaoDe will do its best to learn more about high-quality overseas drugs for you.

xa0